| |
Latest 10 SEC filings (by transaction date) for MTEM within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 4/24 | Apr 2/24 | Lalande Kevin M. | Indirect Ownership | Warrants (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 1,154,154 | $0.125 |
Apr 4/24 | Apr 2/24 | Lalande Kevin M. | Indirect Ownership | Pre-Funded Warrants (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 402,077 | $2.35 |
Apr 4/24 | Apr 2/24 | Lalande Kevin M. | Indirect Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 175,000 | $2.35 |
Apr 4/24 | Apr 2/24 | Biotech Target N V | Direct Ownership | Common Warrants (right to buy) | P - Open market or private purchase | 769,334 | $0.125 |
Apr 4/24 | Apr 2/24 | Biotech Target N V | Direct Ownership | Prefunded Warrants (right to buy) | P - Open market or private purchase | 134,667 | $2.35 |
Apr 4/24 | Apr 2/24 | Biotech Target N V | Direct Ownership | Common Stock | P - Open market or private purchase | 250,000 | $2.35 |
Jan 25/24 | Jan 23/24 | Voi Maurizio | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 10,000 | |
Jan 25/24 | Jan 23/24 | Kim Jason S. | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 10,000 | |
Jan 25/24 | Jan 23/24 | Poma Eric E | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 23,333 | |
Nov 1/23 | Oct 31/23 | Voi Maurizio | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 11,333 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for MTEM within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 4/24 | Apr 2/24 | Lalande Kevin M. | Indirect Ownership | Warrants (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 1,154,154 | $0.125 |
Apr 4/24 | Apr 2/24 | Lalande Kevin M. | Indirect Ownership | Pre-Funded Warrants (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 402,077 | $2.35 |
Apr 4/24 | Apr 2/24 | Lalande Kevin M. | Indirect Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 175,000 | $2.35 |
Apr 4/24 | Apr 2/24 | Biotech Target N V | Direct Ownership | Common Warrants (right to buy) | P - Open market or private purchase | 769,334 | $0.125 |
Apr 4/24 | Apr 2/24 | Biotech Target N V | Direct Ownership | Prefunded Warrants (right to buy) | P - Open market or private purchase | 134,667 | $2.35 |
Apr 4/24 | Apr 2/24 | Biotech Target N V | Direct Ownership | Common Stock | P - Open market or private purchase | 250,000 | $2.35 |
Jan 25/24 | Jan 23/24 | Voi Maurizio | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 10,000 | |
Jan 25/24 | Jan 23/24 | Kim Jason S. | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 10,000 | |
Jan 25/24 | Jan 23/24 | Poma Eric E | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 23,333 | |
Nov 1/23 | Oct 31/23 | Voi Maurizio | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 11,333 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |